TCG Crossover Management »

Kodiak Sciences shares owned by TCG Crossover Management

Quarter-by-quarter ownership of Kodiak Sciences (KOD) shares owned by TCG Crossover Management from 13F filings

Historical chart of TCG Crossover Management investment in Kodiak Sciences

Tip: Access up to 7 years of quarterly data

All positions including Kodiak Sciences held by TCG Crossover Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kodiak Sciences by TCG Crossover Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $4.7M 900k 5.26
2023-12-31 $815k 268k 3.04

More positions owned by TCG Crossover Management

Cg Oncology Comm
Dyne Therapeutics Comm (DYN)
Astria Therapeutics Comm (ATXS)
Silence Therapeutics Adrs (SLN)
Structure Therapeutics Adrs (GPCR)
Aerovate Therapeutics Comm (AVTE)
Inhibrx Comm (INBX)
Keros Therapeutics Comm (KROS)
Geron Corp Comm (GERN)
Savara Comm (SVRA)
Ocular Therapeutix Comm (OCUL)
Cogent Biosciences Comm (COGT)
Edgewise Therapeutics Comm (EWTX)
Mineralys Therapeutics Comm (MLYS)
Madrigal Pharmaceuticals Comm (MDGL)

View all positions for TCG Crossover Management

Top funds holding Kodiak Sciences

Baker Bros. Advisors
BlackRock
Acadian Asset Management
EcoR1 Capital
Vanguard Group
Silverarc Capital Management
D. E. Shaw & Co
ICONIQ Capital
Newtyn Management
Morgan Stanley
TCG Crossover Management
State Street Corporation
Geode Capital Management
Invesco
Board of Trustees of The Leland Stanford Junior University

View all funds holding Kodiak Sciences